PA
BMY icon

Pineridge Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Pineridge Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$265 Hold
6
– – ﹤0.01% 432
2025
Q2 		$268 Hold
6
– – ﹤0.01% 527
2025
Q1 		$349 Sell
6
-260
-98% -$15.2K ﹤0.01% 465
2024
Q4 		$15K Sell
266
-26
-9% -$1.45K 0.01% 251
2024
Q3 		$15.1K Hold
292
– – 0.01% 241
2024
Q2 		$12.1K Sell
292
-20
-6% -$895 ﹤0.01% 261
2024
Q1 		$16.9K Buy
312
+99
+46% +$5.04K 0.01% 237
2023
Q4 		$10.9K Buy
+213
New +$11.2K ﹤0.01% 365

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Pineridge Advisors's BMY Position: Q3 2025 in Review

Pineridge Advisors held its Bristol-Myers Squibb (BMY) position steady in Q3 2025 at 6 shares worth $265. The position accounts for ﹤0.01% of the portfolio, ranked #432.

Pineridge Advisors first reported a position in BMY in Q4 2023 and has held it in 8 quarters since. The position peaked at $16.9K in Q1 2024. 2,267 funds tracked by Wall St. Rank hold BMY as of Q3 2025.

  • Pineridge Advisors held 6 shares of Bristol-Myers Squibb worth $265 as of Q3 2025.
  • Pineridge Advisors left its Bristol-Myers Squibb share count unchanged in Q3 2025.
  • Bristol-Myers Squibb made up ﹤0.01% of Pineridge Advisors's portfolio in Q3 2025, its #432 holding.
  • Pineridge Advisors first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 8 quarters since.
  • Pineridge Advisors's Bristol-Myers Squibb position peaked at $16.9K in Q1 2024.
  • 2,267 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.

Based on Pineridge Advisors's 13F filing for Q3 2025, filed 4 Nov 2025.